- Home
- NXTC vs STKS Comparison
NXTC vs STKS Comparison
Compare NXTC & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXTC | STKS |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.0M | 56.0M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | NXTC | STKS |
|---|---|---|
| Price | $13.37 | $2.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $23.00 | $4.50 |
| AVG Volume (30 Days) | 34.5K | ★ 45.3K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $820,588,000.00 |
| Revenue This Year | N/A | $25.10 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 51.57 |
| 52 Week Low | $2.69 | $1.70 |
| 52 Week High | $15.74 | $5.26 |
Technical Indicators
Market Signals| Indicator | NXTC | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 56.21 | 62.25 |
| Support Level | $12.99 | $1.70 |
| Resistance Level | $13.98 | $2.12 |
| Average True Range (ATR) | 1.00 | 0.10 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 67.65 | 61.02 |
Price Performance
Historical ComparisonAbout NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.